Breast cancer (Tokyo, Japan)
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study.
Masanori Oshi, Tomo Nakayama, Ichiro Ota, Mahato Sasamoto, Akimitsu Yamada, Kazutaka Narui, Kazuaki Takabe, Itaru Endo
Published: 202610.1007/s12282-025-01803-6
No abstract available for this study.